Physician profile
Prashant B Patel
NPI 1982806915
$19,937.04
in general payments reported to CMS, 2019-2025
45 companies · $7,865 in 2025
The $7,865 reported for 2025 was more than what 95% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,598 · 2020: $1,712 · 2021: $1,495 · 2022: $2,447 · 2023: $2,368 · 2024: $2,451 · 2025: $7,865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,274 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,175 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,274.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,175.00 |
| Education | $235.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $5,323.66 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $2,187.32 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,616.82 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Philips North America LLC | $1,383.45 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und, (8874) Incourage |
| Mylan Specialty L.P. | $799.80 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $780.10 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $774.32 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $608.82 | 2021-2025 | Wakix |
| Genzyme Corporation | $584.62 | 2019-2025 | |
| Grifols USA, LLC | $508.61 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $425.95 | 2019-2025 | Dupixent |
| Amgen INC. | $400.21 | 2021-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $341.72 | 2020-2025 | Aralast |
| Electromed, INC. | $270.67 | 2019-2025 | Smartvest |
| Inspire Medical Systems, INC. | $270.42 | 2023-2025 | Inspire |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $270.02 | 2019-2020 | |
| Pulmonx Corporation | $268.94 | 2022-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Novartis Pharmaceuticals Corporation | $228.73 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $224.93 | 2019-2023 | Camzyos |
| Axsome Therapeutics, INC. | $224.37 | 2022-2025 | Sunosi |
| United Therapeutics Corporation | $206.48 | 2022-2025 | Tyvaso, Orenitram |
| Avadel Cns Pharmaceuticals, LLC | $206.30 | 2023-2025 | Lumryz |
| Genentech USA, INC. | $202.42 | 2019-2025 | Xolair |
| Pfizer INC. | $201.07 | 2020-2025 | |
| Insmed, INC. | $189.38 | 2020-2025 | Arikayce, Brinsupri |
| Viatris Specialty LLC | $173.65 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $166.51 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $155.75 | 2021-2025 | Uptravi |
| Verona Pharma, INC. | $128.38 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $115.03 | 2020-2023 | |
| Baxter Healthcare | $112.47 | 2022-2025 | Hillrom - Monarch Airway Clearance System |
| Resmed Corp | $81.28 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $71.29 | 2020-2023 | Belsomra |
| Ani Pharmaceuticals, INC. | $67.18 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $62.39 | 2021-2025 | Acthar |
| Advanced Respiratory, INC | $53.71 | 2020-2021 | |
| Shire North American Group INC | $41.63 | 2019 | |
| Boston Scientific Corporation | $36.26 | 2022-2023 | Watchman |
| Gilead Sciences, INC. | $34.69 | 2021-2024 | |
| International Rehabilitative Sciences, INC | $34.66 | 2024 | Rs 4i Plus Sequential Stimulator |
| Circassia INC. | $29.87 | 2019-2024 | Niox |
| Phadia US INC. | $29.24 | 2023-2024 | Immunocap |
| Optinose US, INC. | $16.37 | 2025 | |
| Covis Pharma Gmbh | $14.55 | 2022 | |
| Inogen, INC. | $13.00 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.